Compare $CAPR vs $MPLT | Chartloom

Compare

$CAPR vs $MPLT

Capricor Therapeutics Inc · MapLight Therapeutics Inc

CAPR

Capricor Therapeutics Inc

MPLT

MapLight Therapeutics Inc

Compare $CAPR vs $MPLT

Comparing Capricor Therapeutics Inc and MapLight Therapeutics Inc

CAPRCapricor Therapeutics Inc

MPLTMapLight Therapeutics Inc

CAPRCapricor Therapeutics Inc

Market cap

$453M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.84x

Rev growth (TTM)

-100.0%

YTD performance

-72.3%

52W performance

4.4%

FCF yield

-28.6%

MPLTMapLight Therapeutics Inc

Market cap

$400M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-47.3%

52W performance

-51.9%

FCF yield

-43.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CAPR

MPLT

Detailed metrics comparison

CAPR

Capricor Therapeutics Inc

MPLT

MapLight Therapeutics Inc

Market Cap

CAPR$453M

MPLT$400M

Enterprise Value

CAPR$433M

MPLT$329M

Price

CAPR$7.83

MPLT$8.83

P/E Ratio

CAPRN/A

MPLTN/A

P/S Ratio

CAPR23.36x

MPLT0.00x

EV/Sales

CAPR22.42x

MPLT0.00x

EV/EBITDA

CAPR1,019.20x

MPLT0.00x

P/B Ratio

CAPR2.11x

MPLT1.57x

P/FCF Ratio

CAPRN/A

MPLTN/A

EV/FCF

CAPR-3.33x

MPLT-1.88x

PEG Ratio

CAPRN/A

MPLTN/A

Forward P/E (NTM)

CAPRN/A

MPLTN/A

Forward P/S (NTM)

CAPR6.84x

MPLTN/A

Revenue (TTM)

CAPR$0

MPLT$0

Revenue Growth (YoY)

CAPR-100.0%

MPLTN/A

Forward Rev Growth

CAPR-27.8%

MPLT949.5%

Gross Margin (TTM)

CAPR0.0%

MPLT0.0%

Operating Margin (TTM)

CAPR0.0%

MPLT0.0%

EBITDA Margin (TTM)

CAPR0.0%

MPLT0.0%

Net Margin (TTM)

CAPR0.0%

MPLT0.0%

FCF Margin (TTM)

CAPRN/A

MPLTN/A

Net Income (TTM)

CAPR$-129M

MPLT$-230M

FCF (TTM)

CAPR$-130M

MPLT$-175M

EPS (TTM)

CAPR-$2.23

MPLT-$5.06

ROE (TTM)

CAPR-5660.0%

MPLT-6384.0%

ROA (TTM)

CAPR-4397.0%

MPLT-6033.0%

ROIC (TTM)

CAPR-5562.0%

MPLT-6384.0%

Cash

CAPR$21M

MPLT$72M

Debt

CAPR$0

MPLT$0

Net Cash/Debt

CAPR$21M

MPLT$72M

Current Ratio (TTM)

CAPR7.35x

MPLT16.52x

Quick Ratio (TTM)

CAPR7.22x

MPLT15.79x

Debt/Equity (TTM)

CAPR0.02x

MPLT0.00x

Debt/Assets (TTM)

CAPR0.0%

MPLT0.0%

Interest Coverage (TTM)

CAPRN/A

MPLTN/A

Net Debt/EBITDA (TTM)

CAPR0.00x

MPLT0.00x

Beta

CAPR0.59

MPLT0.85

52W Performance

CAPR4.4%

MPLT-51.9%

YTD Performance

CAPR-72.3%

MPLT-47.3%

% from 52W High

CAPR-80.6%

MPLT-78.2%

% from 52W Low

CAPR164.5%

MPLT1.5%

Asset Turnover (TTM)

CAPR0.25x

MPLT0.00x

FCF Yield (TTM)

CAPR-28.6%

MPLT-43.7%

Earnings Yield (TTM)

CAPR-28.5%

MPLT-57.4%

Dividend Yield (TTM)

CAPRN/A

MPLTN/A

Rule of 40

CAPR-100.0

MPLT0.0

EV/GP/RG

CAPRN/A

MPLTN/A

Ticker research

View CAPR research View MPLT research

Metric	CAPR Capricor Therapeutics Inc	MPLT MapLight Therapeutics Inc
Market & Valuation
Market Cap	$453M	$400M
Enterprise Value	$433M	$329M
Price	$7.83	$8.83
P/E Ratio	N/A	N/A
P/S Ratio	23.36x	0.00x
EV/Sales	22.42x	0.00x
EV/EBITDA	1,019.20x	0.00x
P/B Ratio	2.11x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.33x	-1.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.84x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	-27.8%	949.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-129M	$-230M
FCF (TTM)	$-130M	$-175M
EPS (TTM)	-$2.23	-$5.06
ROE (TTM)	-5660.0%	-6384.0%
ROA (TTM)	-4397.0%	-6033.0%
ROIC (TTM)	-5562.0%	-6384.0%
Financial Health
Cash	$21M	$72M
Debt	$0	$0
Net Cash/Debt	$21M	$72M
Current Ratio (TTM)	7.35x	16.52x
Quick Ratio (TTM)	7.22x	15.79x
Debt/Equity (TTM)	0.02x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.59	0.85
52W Performance	4.4%	-51.9%
YTD Performance	-72.3%	-47.3%
% from 52W High	-80.6%	-78.2%
% from 52W Low	164.5%	1.5%
Efficiency & Yields
Asset Turnover (TTM)	0.25x	0.00x
FCF Yield (TTM)	-28.6%	-43.7%
Earnings Yield (TTM)	-28.5%	-57.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CAPR research	View MPLT research

Valuation

P/S Ratio

MPLT

0.00x

CAPR

23.36x

EV/FCF

CAPR

-3.33x

MPLT

-1.88x

Growth & revenue

Revenue Growth TTM

CAPR

-100.0%

Forward Revenue Growth

MPLT

949.5%

CAPR

-27.8%

Profitability & performance

Gross Margin

CAPR

0.0%

MPLT

0.0%

ROE

CAPR

-5660.0%

MPLT

-6384.0%

FCF Yield %

CAPR

-28.6%

MPLT

-43.7%

52-Week Performance

CAPR

4.4%

MPLT

-51.9%

Detailed metrics comparison

CAPR

Capricor Therapeutics Inc

MPLT

MapLight Therapeutics Inc

Market Cap

CAPR$453M

MPLT$400M

Enterprise Value

CAPR$433M

MPLT$329M

Price

CAPR$7.83

MPLT$8.83

P/E Ratio

CAPRN/A

MPLTN/A

P/S Ratio

CAPR23.36x

MPLT0.00x

EV/Sales

CAPR22.42x

MPLT0.00x

EV/EBITDA

CAPR1,019.20x

MPLT0.00x

P/B Ratio

CAPR2.11x

MPLT1.57x

P/FCF Ratio

CAPRN/A

MPLTN/A

EV/FCF

CAPR-3.33x

MPLT-1.88x

PEG Ratio

CAPRN/A

MPLTN/A

Forward P/E (NTM)

CAPRN/A

MPLTN/A

Forward P/S (NTM)

CAPR6.84x

MPLTN/A

Revenue (TTM)

CAPR$0

MPLT$0

Revenue Growth (YoY)

CAPR-100.0%

MPLTN/A

Forward Rev Growth

CAPR-27.8%

MPLT949.5%

Gross Margin (TTM)

CAPR0.0%

MPLT0.0%

Operating Margin (TTM)

CAPR0.0%

MPLT0.0%

EBITDA Margin (TTM)

CAPR0.0%

MPLT0.0%

Net Margin (TTM)

CAPR0.0%

MPLT0.0%

FCF Margin (TTM)

CAPRN/A

MPLTN/A

Net Income (TTM)

CAPR$-129M

MPLT$-230M

FCF (TTM)

CAPR$-130M

MPLT$-175M

EPS (TTM)

CAPR-$2.23

MPLT-$5.06

ROE (TTM)

CAPR-5660.0%

MPLT-6384.0%

ROA (TTM)

CAPR-4397.0%

MPLT-6033.0%

ROIC (TTM)

CAPR-5562.0%

MPLT-6384.0%

Cash

CAPR$21M

MPLT$72M

Debt

CAPR$0

MPLT$0

Net Cash/Debt

CAPR$21M

MPLT$72M

Current Ratio (TTM)

CAPR7.35x

MPLT16.52x

Quick Ratio (TTM)

CAPR7.22x

MPLT15.79x

Debt/Equity (TTM)

CAPR0.02x

MPLT0.00x

Debt/Assets (TTM)

CAPR0.0%

MPLT0.0%

Interest Coverage (TTM)

CAPRN/A

MPLTN/A

Net Debt/EBITDA (TTM)

CAPR0.00x

MPLT0.00x

Beta

CAPR0.59

MPLT0.85

52W Performance

CAPR4.4%

MPLT-51.9%

YTD Performance

CAPR-72.3%

MPLT-47.3%

% from 52W High

CAPR-80.6%

MPLT-78.2%

% from 52W Low

CAPR164.5%

MPLT1.5%

Asset Turnover (TTM)

CAPR0.25x

MPLT0.00x

FCF Yield (TTM)

CAPR-28.6%

MPLT-43.7%

Earnings Yield (TTM)

CAPR-28.5%

MPLT-57.4%

Dividend Yield (TTM)

CAPRN/A

MPLTN/A

Rule of 40

CAPR-100.0

MPLT0.0

EV/GP/RG

CAPRN/A

MPLTN/A

Ticker research

View CAPR research View MPLT research

Metric	CAPR Capricor Therapeutics Inc	MPLT MapLight Therapeutics Inc
Market & Valuation
Market Cap	$453M	$400M
Enterprise Value	$433M	$329M
Price	$7.83	$8.83
P/E Ratio	N/A	N/A
P/S Ratio	23.36x	0.00x
EV/Sales	22.42x	0.00x
EV/EBITDA	1,019.20x	0.00x
P/B Ratio	2.11x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.33x	-1.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.84x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	-27.8%	949.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-129M	$-230M
FCF (TTM)	$-130M	$-175M
EPS (TTM)	-$2.23	-$5.06
ROE (TTM)	-5660.0%	-6384.0%
ROA (TTM)	-4397.0%	-6033.0%
ROIC (TTM)	-5562.0%	-6384.0%
Financial Health
Cash	$21M	$72M
Debt	$0	$0
Net Cash/Debt	$21M	$72M
Current Ratio (TTM)	7.35x	16.52x
Quick Ratio (TTM)	7.22x	15.79x
Debt/Equity (TTM)	0.02x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.59	0.85
52W Performance	4.4%	-51.9%
YTD Performance	-72.3%	-47.3%
% from 52W High	-80.6%	-78.2%
% from 52W Low	164.5%	1.5%
Efficiency & Yields
Asset Turnover (TTM)	0.25x	0.00x
FCF Yield (TTM)	-28.6%	-43.7%
Earnings Yield (TTM)	-28.5%	-57.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CAPR research	View MPLT research